biote Corp (NASDAQ:BTMD) — Market Cap & Net Worth
Market Cap & Net Worth: biote Corp (BTMD)
biote Corp (NASDAQ:BTMD) has a market capitalization of $54.78 Million ($54.78 Million) as of May 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #21533 globally and #4580 in its home market, demonstrating a -1.35% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying biote Corp's stock price $2.19 by its total outstanding shares 32046352 (32.05 Million). Analyse biote Corp (BTMD) cash conversion ratio to see how efficiently the company converts income to cash.
biote Corp Market Cap History: 2021 to 2026
biote Corp's market capitalization history from 2021 to 2026. Data shows change from $314.05 Million to $70.18 Million (-26.22% CAGR).
Index Memberships
biote Corp is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.41 Trillion | 0.00% | #614 of 976 |
|
NASDAQ Composite
IXIC
|
$38.77 Trillion | 0.00% | #2073 of 3165 |
Weight: biote Corp's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
biote Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how biote Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.43x
biote Corp's market cap is 0.43 times its annual revenue
Latest Price to Earnings (P/E) Ratio
3.08x
biote Corp's market cap is 3.08 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $314.05 Million | $139.40 Million | $32.62 Million | 2.25x | 9.63x |
| 2022 | $119.53 Million | $164.96 Million | -$969.00K | 0.72x | N/A |
| 2023 | $158.31 Million | $185.36 Million | $3.32 Million | 0.85x | 47.74x |
| 2024 | $198.05 Million | $197.19 Million | $3.16 Million | 1.00x | 62.73x |
| 2025 | $83.32 Million | $192.22 Million | $27.05 Million | 0.43x | 3.08x |
Competitor Companies of BTMD by Market Capitalization
Companies near biote Corp in the global market cap rankings as of May 4, 2026.
Key companies related to biote Corp by market ranking:
- HCA Holdings Inc (NYSE:HCA): Ranked #256 globally with a market cap of $96.85 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #962 globally with a market cap of $27.16 Billion USD ( €23.23 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #972 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- IHH Healthcare Bhd (KLSE:5225): Ranked #1292 globally with a market cap of $19.57 Billion USD ( RM77.93 Billion MYR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #256 | HCA Holdings Inc | NYSE:HCA | $96.85 Billion | $433.09 |
| #962 | Fresenius SE & Co. KGaA | XETRA:FRE | $27.16 Billion | €41.25 |
| #972 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1292 | IHH Healthcare Bhd | KLSE:5225 | $19.57 Billion | RM8.82 |
biote Corp Historical Marketcap From 2021 to 2026
Between 2021 and today, biote Corp's market cap moved from $314.05 Million to $ 70.18 Million, with a yearly change of -26.22%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $70.18 Million | -15.77% |
| 2025 | $83.32 Million | -57.93% |
| 2024 | $198.05 Million | +25.10% |
| 2023 | $158.31 Million | +32.44% |
| 2022 | $119.53 Million | -61.94% |
| 2021 | $314.05 Million | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of biote Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $54.78 Million USD |
| MoneyControl | $54.78 Million USD |
| MarketWatch | $54.78 Million USD |
| marketcap.company | $54.78 Million USD |
| Reuters | $54.78 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About biote Corp
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with … Read more